About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Johnson & Johnson: Taking The Bull By The Horns?

Johnson & Johnson stock price

Johnson & Johnson (NYSE: JNJ) recently filed a shelf registration with the SEC, suggesting it is preparing for the future. The filing is for debt securities, not shares, to be sold on an ongoing basis at a future date that could be as soon as the filing was received. The offering aims to raise capital for general corporate purposes, servicing/restructuring debt, repurchasing shares, CAP EX or acquisitions. Given the recent Fitch Solutions report, CAP EX and acquisitions may be on the minds of Johnson & Johnson executives. 

A Patent Cliff Is Approaching For Pharma Companies

Fitch outlines how companies from AstraZeneca (NYSE: AZN) to AbbVie (NYSE: ABBV), already facing patent-related pressure, are approaching a patent cliff and Johnson & Johnson is not immune. A patent cliff is when patents on blockbuster drugs like AbbVie’s Humira expire and open the door to competition. This means generic manufacturers will be flooding the market with biosimilar compounds, which is a big hit on the top and bottom lines for the world’s leading pharma companies. 

In the case of Johnson & Johnson, its blockbuster Stellara loses patent protection this year and another major contributor, Simponi, loses its protection in 2024. Between them, they account for more than 20% of Pharma segment incomes which is the company’s core business. The company must replace these products and having the capital to invest is crucial. 

As far as the pipeline goes, Johnson & Johnson has about 40 compounds in Phase 3 trials but many of those are for approvals for additional indications for existing medicines like Stellara and Simponi. In this light, it is unclear how much potential the pipeline has for the company.

Additionally, JNJ was recently reported to be “quietly” overhauling the pharma segment. According to the report, the overhaul includes the consolidation of sub-segments, thousands of layoffs, and discontinuation of non-productive pipeline candidates. 

Are Acquisitions On Tap For 2023? 

The assumption is that Johnson & Johnson is searching for a takeover candidate with either a promising pipeline or a drug already on the market. Estimates for 2023 takeover activity are $250 billion for the industry, so J&J is not the only big pharma name to watch. Among the top candidates for takeover are Ascendis Pharma (NASDAQ: ASND) and Athira Pharma (NASDAQ: ATHA). Ascendis Pharma is a young but established pharma with hopes of joining the big players, while Athira Pharma focuses on Alzheimer’s treatments. 

Johnson & Johnson’s Dividend Is Safe Enough For Now 

While you can never completely rule out a dividend cut or suspension, it is doubtful that Johnson & Johnson will do so anytime soon. The company has a solid balance sheet despite its use of debt, and healthy cash flows, and pays out only a small amount of its earnings. The payout ratio is 43% which is low for regular stock and JNJ stock is a Dividend King with 60 years of consecutive increases. That’s a lot of history to throw away, which is not something JNJ execs will do lightly. 

Looking at the chart, the fear of the patent cliff is opening an opportunity. The price action in JNJ is retreating to support near the long-term uptrend line where the market is likely to step in and support prices. The stock price may fall below the trend line and even enter a trading range. If so, Johnson & Johnson is still at least a Hold for its 2.8% yield and buyable when it confirms support at accepted technical targets. 

Johnson & Johnson: Prepping For The Future? 

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.